---
title: "KMDA.US (KMDA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KMDA.US/news.md"
symbol: "KMDA.US"
name: "KMDA.US"
parent: "https://longbridge.com/en/quote/KMDA.US.md"
datetime: "2026-06-13T22:05:04.549Z"
locales:
  - [en](https://longbridge.com/en/quote/KMDA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KMDA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KMDA.US/news.md)
---

# KMDA.US (KMDA.US) — Related News

### [Weekly Buzz: PHG, KMDA Win FDA Nod; FULC Halts Pociredir; RMD Closes Noctrix Deal; NVS Paces In IgAN](https://longbridge.com/en/news/288878717.md)
*2026-06-05T14:32:23.000Z*
> This week, the biotech sector saw FDA approvals for Philips' AI ultrasound and Lupin's oncology/ophthalmology drugs, whi

### [Kamada Receives FDA Approval For In-House Rabies Virus Neutralization Testing Laboratory](https://longbridge.com/en/news/288277915.md)
*2026-06-01T12:55:27.000Z*
> Kamada Ltd. announced that the U.S. FDA has approved its new in-house rabies virus neutralization testing laboratory. Th

### [](https://longbridge.com/en/news/286289891.md)
*2026-05-13T15:47:56.000Z*
> Kamada shares are trading lower after the company reported worse-than-expected Q1 financial results.

### [Veritone Q1 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/286110545.md)
*2026-05-12T13:31:07.000Z*
> Veritone (NASDAQ:VERI) reported Q1 2026 revenue of $20.3 million, a slight decrease from the previous year. The company 

### [Kamada Q1 2026 earnings preview](https://longbridge.com/en/news/286130839.md)
*2026-05-12T16:11:18.000Z*
> Kamada (KMDA) will announce its Q1 earnings on May 13th, with a consensus EPS estimate of $0.12 (+71.4% Y/Y) and revenue

### [Kamada Ltd. (NASDAQ:KMDA) Short Interest Update](https://longbridge.com/en/news/284466893.md)
*2026-04-29T00:33:21.000Z*
> Kamada Ltd. (NASDAQ:KMDA) experienced a significant drop in short interest, falling 32.5% to 109,877 shares as of April